director of the Interventional Therapy department

chief physician, Master of medicine

He resigned as director of Jilin People's Hospital and joined the Guowen Medical corporation Changchun hospital.

He has been engaged in interventional oncology for 25 years. Regional targeted therapy for primary liver cancer and metastatic liver cancer, interventional therapy for digestive tract tumors/liver metastases/lung cancer/pelvic tumors/obstructive jaundice/tumor complications, and image-guided percutaneous particle implantation for solid tumors were carried out simultaneously at the Department of Interventional Therapy, Peking University Cancer Hospital. Continuous infusion chemotherapy is a breakthrough in the treatment of liver metastases by delivering targeted regional infusion chemotherapy/thrombec-based therapy in the hepatic artery or portal vein (embedded pump).